121 related articles for article (PubMed ID: 26095141)
1. Radial expansion rates and tumor growth kinetics predict malignant transformation in contrast-enhancing low-grade diffuse astrocytoma.
Hathout L; Pope WB; Lai A; Nghiemphu PL; Cloughesy TF; Ellingson BM
CNS Oncol; 2015; 4(4):247-56. PubMed ID: 26095141
[TBL] [Abstract][Full Text] [Related]
2. Potential Utility of Visually AcceSAble Rembrandt Images Assessment in Brain Astrocytoma Grading.
Yu J; Wang M; Song J; Huang D; Hong X
J Comput Assist Tomogr; 2016; 40(2):301-6. PubMed ID: 26978002
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature.
Chaichana KL; McGirt MJ; Niranjan A; Olivi A; Burger PC; Quinones-Hinojosa A
Neurol Res; 2009 Nov; 31(9):931-9. PubMed ID: 19215664
[TBL] [Abstract][Full Text] [Related]
4. Karyometric features of low and high grade glial tumors as compared with their MRI appearance.
Scarpelli M; Montironi R; Salvolini U; Messori A; Bartels PH
Anal Quant Cytol Histol; 2004 Apr; 26(2):87-96. PubMed ID: 15131896
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic imaging of high-grade astrocytoma: heterogeneity of clinical manifestation, image characteristics, and histopathological findings].
Okajima K; Ohta Y
Brain Nerve; 2012 Oct; 64(10):1151-7. PubMed ID: 23037605
[TBL] [Abstract][Full Text] [Related]
6. Differentiation between Solitary Cerebral Metastasis and Astrocytoma on the Basis of Subventricular Zone Involvement on Magnetic Resonance Imaging.
Wang R; Ma J; Niu G; Zheng J; Liu Z; Du Y; Yu B; Yang J
PLoS One; 2015; 10(7):e0133480. PubMed ID: 26197398
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging characteristics of pilomyxoid astrocytoma.
Komotar RJ; Zacharia BE; Sughrue ME; Mocco J; Carson BS; Tihan T; Otten ML; Burger PC; Garvin JH; Khandji AG; Anderson RC
Neurol Res; 2008 Nov; 30(9):945-51. PubMed ID: 18662499
[TBL] [Abstract][Full Text] [Related]
8. [The heterogeneity of blood flow on magnetic resonance imaging: a biomarker for grading cerebral astrocytomas].
Revert Ventura AJ; Sanz Requena R; Martí-Bonmatí L; Pallardó Y; Jornet J; Gaspar C
Radiologia; 2014; 56(4):328-38. PubMed ID: 22738943
[TBL] [Abstract][Full Text] [Related]
9. Use of preoperative FLAIR MRI and ependymal proximity of tumor enhancement as surrogate markers of brain tumor origin.
Smith TR; Hulou MM; Abecassis J; Das S; Chandler JP
J Clin Neurosci; 2015 Sep; 22(9):1397-402. PubMed ID: 26055954
[TBL] [Abstract][Full Text] [Related]
10. Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas.
Chaichana KL; McGirt MJ; Laterra J; Olivi A; Quiñones-Hinojosa A
J Neurosurg; 2010 Jan; 112(1):10-7. PubMed ID: 19361270
[TBL] [Abstract][Full Text] [Related]
11. Rapid malignant transformation of low-grade astrocytoma in a pregnant woman.
Hanada T; Rahayu TU; Yamahata H; Hirano H; Yoshioka T; Arita K
J Obstet Gynaecol Res; 2016 Oct; 42(10):1385-1389. PubMed ID: 27356501
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors.
Sankar T; Moore NZ; Johnson J; Ashby LS; Scheck AC; Shapiro WR; Smith KA; Spetzler RF; Preul MC
J Neurosurg; 2012 Jun; 116(6):1172-81. PubMed ID: 22424566
[TBL] [Abstract][Full Text] [Related]
13. Rapid malignant transformation of low-grade astrocytomas: report of 2 cases and review of the literature.
Frazier JL; Johnson MW; Burger PC; Weingart JD; Quinones-Hinojosa A
World Neurosurg; 2010 Jan; 73(1):53-62; discussion e5. PubMed ID: 20452869
[TBL] [Abstract][Full Text] [Related]
14. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response.
Law M; Oh S; Babb JS; Wang E; Inglese M; Zagzag D; Knopp EA; Johnson G
Radiology; 2006 Feb; 238(2):658-67. PubMed ID: 16396838
[TBL] [Abstract][Full Text] [Related]
15. Neuroradiological viewpoint on the diagnostics of space-occupying brain lesions.
Faehndrich J; Weidauer S; Pilatus U; Oszvald A; Zanella FE; Hattingen E
Clin Neuroradiol; 2011 Sep; 21(3):123-39. PubMed ID: 21538040
[TBL] [Abstract][Full Text] [Related]
16. Tumor blood volume: a prognostic biomarker for anaplastic astrocytomas?
Ginat DT; Rajiv M
CNS Oncol; 2014 Mar; 3(2):97-8. PubMed ID: 25055013
[No Abstract] [Full Text] [Related]
17. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ
Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
[TBL] [Abstract][Full Text] [Related]
18. Revisiting anaplastic astrocytomas II: further characterization of an expansive growth pattern with visually enhanced diffusion tensor imaging.
Guan X; Lai S; Lackey J; Shi J; Techavipoo U; Moulding HD; Flanders AE; Andrews DW
J Magn Reson Imaging; 2008 Dec; 28(6):1322-36. PubMed ID: 19025901
[TBL] [Abstract][Full Text] [Related]
19. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.
Babu R; Bagley JH; Park JG; Friedman AH; Adamson C
J Neurosurg; 2013 Aug; 119(2):434-41. PubMed ID: 23662821
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
